Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769524019 | Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3769525018 | Gemtuzumab ozogamicin 5 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Gemtuzumab ozogamicin | true | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Gemtuzumab ozogamicin | true | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Gemtuzumab ozogamicin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product containing monoclonal antibody (product) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Medicinal product acting as antineoplastic agent (product) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | gemtuzumab ozogamicine | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a pour principe actif (attribut) | Gemtuzumab ozogamicin | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a pour principe actif (attribut) | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a pour principe actif (attribut) | Biological agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a pour principe actif (attribut) | Antineoplastic agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Powder for solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR